Modulation of Vascular Smooth Muscle Cells Proteoglycan Synthesis by the Extracellular Matrix

Journal of Cellular Physiology

Volumn 198, Issue 2, 2004, Pages 302-309

  Figueroa, Julio F ^a   Oubre, John ^a   Vijayagopal, Parakat ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN; ELASTIN; PROTEOGLYCAN;

ARTICLE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MACROPHAGE; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

CELL DIVISION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEOGLYCANS;

EID: 1642498352     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10414     Document Type: Article

References (30)

1. Bashkin P, Doctrow S, Klagsburn M, Svahn MC, Folkman J, Vlodavsky I. 1989. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737-1743.
2. Camejo G. 1982. The interaction of lipids and lipoproteins with the extracellular matrix of arterial tissue. Adv Lipid Res 19:1-53.
3. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G. 1993. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268:14131-14137.
4. Campbell JH, Campbell GR. 1994. The role of smooth muscle cells in atherosclerosis. Curr Opin Lipidol 5:322-330.
5. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. 1992. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp Cell Res 200:156-167.
6. Carlson DM. 1968. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J Biol Chem 243:616-626.
7. Chamley-Campbell JH, Campbell GR. 1981. What controls smooth muscle phenotype? Atherosclerosis 40:347-352.
8. Ciolino HP, Vijayagopal P, Radhakrishnamurthy B, Berenson GS. 1992. Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while suppressing cell proliferation. Atherosclerosis 94:135-146.
9. Edwards IJ, Wagner WD, Owens RT. 1990. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am J Pathol 136:609-621.
10. Frize LMS, Reilly CF, Rosenberg RD. 1985. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol 100:1041-1049.
11. Gowda DC, Bhavanandan VP, Davidson EA. 1986. Isolation and characterization of proteoglycans secreted by normal and malignant human mammary epithelial cells. J Biol Chem 261:4926-4934.
12. Hara H, Tanishita H, Yokoyama S, Tajima S, Yamamoto A. 1987. Induction of acetylated low density lipoprotein receptor and suppression of low density lipoprotein receptor on the cells of human monocytic leukemia cell line (THP-1 cell). Biochem Biophys Res Commun 187:802-808.
13. Heickendorf L, Ledet T, Rasmussen LM. 1994. Glycosaminoglycans in human aorta in diabetes mellitus. Diabetologia 37:286-292.
14. Hoff H, Wagner W. 1986. Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modification in aortic glycosaminoglycan composition. Atherosclerosis 61:231-236.
15. Hosenpud JD, Chou S, Wagner CR. 1991. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 52:896-903.
16. Jones PA, Scott-Burden T, Gevers W. 1979. Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci USA 76:353-357.
17. Ju H, Dixon IM. 1996. Extracellular matrix and cardiovascular diseases. Can J Cardiol 12:1259-1267.
18. Raghow R. 1994. The extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823-831.
19. Saito H, Yamagata T, Suzuki S. 1968. Enzymatic methods of the determination of small quantities of isomeric chondroitin sulfate. J Biol Chem 243:1536-1542.
20. Sarphie TG, Deaciuc IV, Spitzer JJ, D'Souza NB. 1995. Liver sinusoid during chronic alcohol consumption in the rat: An electron microscopic study. Alcohol Clin Exp Res 19:291-298.
21. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. 1991. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266: 17640-17647.
22. Scott-Burden T, Resink TJ, Burgin M, Buhler FR. 1989. Extracellular matrix: Differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats. J Cell Physiol 141:267-274.
23. Tao Z, Smart FW, Figueroa JE, Glancy DL, Vijayagopal P. 1997. Elevated expression of proteoglycans in proliferating vascular smooth muscle cells. Atherosclerosis 135:171-179.
24. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger B. 1990. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966-990.
25. Vijayagopal P. 1993. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. Biochem J 294:603-611.
26. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. 1981. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem 256:8234-8241.
27. Walker-Caprioglio HM, Koob TJ, McGuffee LJ. 1992. Proteoglycan synthesis in normotensive and spontaneously hypertensive rat arteries in vitro. Matrix 12:308-320.
28. Wasteson A, Lindahl U, Hallen A. 1972. Mode of degradation of the chondroitin sulphate proteoglycan in rat costal cartilage. Biochem J 130:729-738.
29. Wight TN. 1989. Cell biology of arterial proteoglycans. Arteriosclerosis 9:1-20.
30. Wight TN. 1995. The extracellular matrix and atherosclerosis. Curr Opin Lipidol 6:326-334.